USD 49.4 billion
Precision Immuno-Oncology Market Size, Share, Growth Analysis, By End use(Hospital, Clinics, research institutes and others), By Cancer type(Lung cancer, breast cancer, prostate cancer, melanoma and others), By Treatment type(checkpoint inhibitors, car T cell therapy, cancer vaccines, and others), By Biomarker(PD-L1, BRCA, KRAS, EGFR), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2063 |
Region:
Global |
Published Date: July, 2024
Pages:
157
|Tables:
121
|Figures:
77
Precision Immuno-Oncology Market Insights
Precision Immuno-Oncology Market size was valued at USD 54.74 billion in 2022 and is poised to grow from USD 60.65 billion in 2023 to USD 137.77 billion by 2031, growing at a CAGR of 10.80% in the forecast period (2024-2031).
Precision immuno-oncology is becoming popular since It allows for a personalized treatment approach based on patients, genetic makeup, tumor characteristics and immune system. This approach can reduce side effects compared to traditional cancer treatments and improve outcomes.
The various advantages of precision immuno-oncology are personalized treatment, increased efficacy, reduced toxicity, potential for long term remissions, and growing market. Precision immuno-oncology is a relatively new field of cancer treatment that aims to provide personalized care to patients based on their genetic makeup, tumor characteristics, and immune system. This approach involves using advanced diagnostic tools to identify specific genetic mutations and proteins expressed by cancer cells, which can then be targeted with precision therapies. By tailoring treatments to the individual patient, precision immuno-oncology has the potential to improve treatment outcomes and reduce side effects compared to traditional cancer treatments that are not personalized. The personalized treatment approach of precision immuno-oncology is a major advantage of this emerging field. This approach allows for a more precise and targeted therapy that can address the unique genetic and immunological factors that contribute to a patient's cancer. By understanding the specific molecular profile of the patient's tumor, physicians can develop a customized treatment plan that is more likely to be effective and less likely to cause harmful side effects. It has shown promise in several clinical trials, where patients with advanced cancers that were previously resistant to treatment have experienced remarkable responses to precision immuno-oncology therapies. In addition, because these therapies are highly specific, they can spare healthy tissues from unnecessary damage, leading to a better quality of life for patients. The market is a rapidly expanding sector within the pharmaceutical industry, with an increasing number of companies investing in research and development of these treatments.
This trend reflects the growing recognition of the potential of precision immuno-oncology to revolutionize cancer treatment. As more research is conducted and more success stories emerge, there is a growing awareness of the potential impact of precision immuno-oncology on cancer treatment. This has led to a surge of interest and investment from pharmaceutical companies, who see the potential of this field to provide more effective and personalized treatments to patients.
US Precision Immuno-Oncology Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Checkpoint inhibitors.
Fastest Growth
Call T cell therapy.
Growth Rate
10.8% CAGR
Global precision immuno-oncology Market 2021-2030 ($ Bn)
Country Share for North America Region- 2021 (%)
To get more reports on the above market click here to Buy The Report
Precision Immuno-Oncology Market Segmental Analysis
Precision Immuno-Oncology Market is segmented on the basis of Treatment type, cancer type, end-user, biomarker, and region. By end use, the Precision Immuno-Oncology Market is segmented into hospitals, clinics, research institutes, and others. By cancer type, the Precision Immuno-Oncology Market is segmented into Lung cancer, Breast cancer, Prostate cancer, Melanoma, and others. By treatment type, the Precision Immuno-Oncology Market is segmented into immune checkpoint inhibitors, car T cell therapy, cancer vaccines, and others. By biomarker, the Precision Immuno-Oncology Market is segmented into PD-L1, BRCA, KRAS, EGFR, and others. By region, the Precision Immuno-Oncology Market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Precision Immuno-Oncology Market Analysis by Treatment Type
By treatment type, the global market is divided into many segments such as checkpoint inhibitors, car T cell therapy, cancer vaccines, and others. The current leader in the precision immuno-oncology market is immune checkpoint inhibitors. These treatments inhibit the proteins that cancer cells use to avoid the immune system, allowing the immune system to recognize and fight cancer cells more effectively.
The precision immuno-oncology market is witnessing a rapid growth in the CAR-T cell therapy segment, which is currently the fastest-growing segment. CAR-T cell therapy involves genetically modifying a patient's own T cells to recognize and attack cancer cells, leading to a potentially more effective treatment option for certain types of blood cancers. This therapy has shown promising results in clinical trials and has the potential to be further developed for other types of cancers. With ongoing research and development, CAR-T cell therapy is expected to become a major player in the precision immuno-oncology market.
Global precision immuno-oncology Market By treatment type2021 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Precision Immuno-Oncology Market Regional Insights
Globally, The precision immuno-oncology market is primarily dominated by North America, which can be attributed to factors such as high healthcare expenditure, favorable reimbursement policies, and a large patient population.
However, the Asia Pacific region is projected to emerge as the fastest-growing market in the near future. This growth can be attributed to several factors, including the increasing prevalence of cancer, growing healthcare infrastructure, and rising demand for advanced cancer treatments. The Asia Pacific region also has a large population base, which presents a significant opportunity for market growth in the coming years.
Global precision immuno-oncology Market By Geography, 2021-2030
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Precision Immuno-Oncology Market Dynamics
Precision Immuno-Oncology Market Drivers
Growing Incidences of Cancer to Bolster Demand for Precision immuno-oncology
- Cancer continues to be a major health concern globally, and the incidence of cancer is increasing. This trend is driving demand for more effective cancer treatments. Traditional cancer treatments, such as chemotherapy and radiation therapy, have limitations and can cause side effects that can be debilitating for patients. Precision immuno-oncology offers a promising approach for improving cancer treatment outcomes by leveraging the patient's own immune system to fight cancer. As the demand for more effective cancer treatments grows, precision immuno-oncology has emerged as a key driver of the market. This approach offers the potential for more precise and targeted therapies that can be tailored to the individual patient's genetic makeup, tumor characteristics, and immune system. This personalized approach has the potential to improve treatment outcomes and reduce side effects compared to traditional cancer treatments that are not personalized.
Precision Immuno-Oncology Market Restraints
High Cost to Hinder Market Growth
- One of the main restraints facing precision immuno-oncology is the cost of these treatments. Compared to traditional cancer treatments, precision immuno-oncology therapies can be more expensive due to their personalized approach and the complexity of the therapy. The cost can be a significant barrier to accessing these treatments for many patients, particularly those living in developing countries where healthcare resources are limited. The cost of precision immuno-oncology is influenced by various factors, such as the high cost of research and development, the need for specialized equipment, and the use of biomarker testing to identify suitable candidates for therapy. Additionally, the personalized nature of precision immuno-oncology treatments means that each patient's treatment plan is unique, which can further drive up costs. The high cost of precision immuno-oncology can limit access to these treatments, resulting in unequal access to effective cancer care. This is particularly true for patients from low- and middle-income countries, where healthcare resources are often limited. The lack of access to these treatments can exacerbate existing disparities in cancer care and outcomes.
Request Free Customization of this report to help us to meet your business objectives.
Precision Immuno-Oncology Market Competitive Landscape
In the coming years, the competition in the global precision immuno-oncology market is expected to intensify, with the entry of new players and the increasing number of treatments compatible with precision immuno-oncology. Currently, there are only a few major players operating in the global market. However, this is likely to change in the forecast period as more companies aim to offer their precision immuno-oncology services. The growing demand for precision immuno-oncology treatments and the potential benefits it offers for cancer patients are driving the entry of new players into the market. As a result, established companies in the cancer treatment industry and emerging start-ups are investing in research and development of precision immuno-oncology therapies. The intensifying competition in the precision immuno-oncology market is expected to lead to innovation and new product development, which could result in more effective treatments for cancer patients.
However, increased competition may also lead to pricing pressures, which could limit profitability for some companies. To stay competitive in the market, companies need to focus on developing innovative and effective precision immuno-oncology therapies, as well as investing in marketing and sales strategies to reach more patients. Collaboration and partnerships between companies may also be necessary to accelerate the development and commercialization of new precision immuno-oncology treatments.
Precision Immuno-Oncology Market Top Player’s Company Profiles
- Adaptimmune Therapeutics plc
- Agenus Inc.
- Amgen Inc.
- AstraZeneca plc
- Bristol Myers Squibb Company
- Celgene Corporation
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- Iovance Biotherapeutics, Inc.
- Juno Therapeutics, Inc.
- Kite Pharma, Inc.
- Merck & Co., Inc.
- Neon Therapeutics, Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Seattle Genetics, Inc.
- Takeda Pharmaceutical Company Limited
Precision Immuno-Oncology Market Recent Developments
- In February 2022, Varian Biopharmaceuticals, a company that specializes in precision oncology and is developing innovative cancer therapeutics, entered into a merger agreement with SPK Acquisition Corp., a special purpose acquisition company. As a result of this business combination, Varian Bio will become a publicly traded company. The focus of Varian Bio's research and development is on a high-potency, specific atypical protein kinase C iota inhibitor, which has the potential to be a best-in-class treatment for various oncology indications. Initially, Varian Bio is targeting the treatment of basal cell carcinoma and molecularly targeted solid tumors.
Precision Immuno-Oncology Key Market Trends
- Precision immuno-oncology treatments are often used in combination with other cancer therapies such as chemotherapy and radiation therapy. This combination approach is becoming increasingly common as it has the potential to enhance treatment efficacy and reduce resistance to treatment. For example, the use of immunotherapy in combination with chemotherapy has shown promising results in treating certain types of cancer such as lung cancer and melanoma. By using both therapies together, the chemotherapy can help to shrink the tumor while the immunotherapy can help the patient's immune system to better recognize and attack cancer cells. In addition, combination therapies can also help to overcome resistance to treatment. Cancer cells are known to develop resistance to specific therapies over time, which can limit their effectiveness. By using combination therapies, doctors can attack cancer cells through multiple pathways, making it more difficult for the cancer cells to develop resistance.
Precision Immuno-Oncology Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
Based on our analysis of the global precision immuno-oncology market, we expect to see significant growth during the forecast period due to the numerous advantages that it offers. These advantages include personalized treatment, increased efficacy, reduced toxicity, potential for long-term remissions, and a growing market. Traditional cancer treatments such as chemotherapy and radiation therapy often have limitations and can cause debilitating side effects for patients. In contrast, precision immuno-oncology offers a promising approach to improve cancer treatment outcomes by leveraging the patient's own immune system to fight cancer. Additionally, precision immuno-oncology treatments can improve treatment convenience for patients.
Given the anticipated high growth rate and demand, the precision immuno-oncology market presents significant potential for new players to enter the market and capitalize on the increasing demand for personalized and effective cancer treatments.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 54.74 billion |
| Market size value in 2031 | USD 137.77 billion |
| Growth Rate | 10.80% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Precision Immuno-Oncology Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Precision Immuno-Oncology Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Precision Immuno-Oncology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Precision Immuno-Oncology Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Precision Immuno-Oncology Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Precision Immuno-Oncology Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
